Wayfinding Financial’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$475K Buy
2,001
+12
+0.6% +$2.49K 0.18% 85
2026
Q1
$420K Sell
1,989
-10
-0.5% -$2.15K 0.18% 81
2025
Q4
$410K Buy
1,999
+13
+0.7% +$2.45K 0.17% 84
2025
Q3
$311K Sell
1,986
-8
-0.4% -$1.24K 0.13% 99
2025
Q2
$316K Sell
1,994
-13
-0.6% -$1.93K 0.14% 95
2025
Q1
$276K Buy
2,007
+12
+0.6% +$1.53K 0.12% 104
2024
Q4
$236K Buy
+1,995
New +$233K 0.13% 114
2024
Q2
Sell
-2,667
Closed -$259K 127
2024
Q1
$259K Buy
2,667
+189
+8% +$20.4K 0.15% 97
2023
Q4
$249K Sell
2,478
-426
-15% -$42.3K 0.17% 92
2023
Q3
$252K Buy
2,904
+190
+7% +$17.2K 0.19% 90
2023
Q2
$248K Buy
+2,714
New +$229K 0.17% 93

Other funds holding CAH

Wayfinding Financial's CAH Position: Q2 2026 in Review

Wayfinding Financial increased its Cardinal Health (CAH) stake by 0.6% in Q2 2026, buying an estimated $2.49K and bringing the position to 2,001 shares worth $475K. The position accounts for 0.18% of the portfolio, ranked #85.

Wayfinding Financial first reported a position in CAH in Q2 2023 and has held it in 11 quarters since. 1,498 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • Wayfinding Financial held 2,001 shares of Cardinal Health worth $475K as of Q2 2026.
  • Wayfinding Financial bought 12 Cardinal Health shares in Q2 2026, an estimated $2.49K.
  • Cardinal Health made up 0.18% of Wayfinding Financial's portfolio in Q2 2026, its #85 holding.
  • Wayfinding Financial first reported a position in Cardinal Health in Q2 2023 and has held it in 11 quarters since.
  • 1,498 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Wayfinding Financial's 13F filing for Q2 2026, filed 13 Aug 2026.